The most scientifically interesting probiotic on the market. Akkermansia muciniphila is a next-generation strain with published data linking it to GLP-1 production and metabolic health. The Depommier 2019 Nature Medicine trial is legitimate science. Clostridium butyricum is a well-studied butyrate producer. However, exact CFU counts are not disclosed (strain-specific dose), and human longevity evidence remains preliminary. Premium science, premium price, early-stage evidence.
The set is generated, never written by the brand.
Pendulum GLP-1 Probiotic: the formulation holds up. Lead: Akkermansia muciniphila at Strain-specific dose. The most scientifically interesting probiotic on the market. Clinical dose on the primary, and the panel holds together.
The most scientifically interesting probiotic in 2026. Akkermansia muciniphila is a next-gen strain linked to metabolic health and GLP-1 production. The Ozempic-adjacent marketing is savvy, but the underlying gut science is real. $79/month for cutting-edge microbiology.
3 of 3 shown

This read comes from the product's own supplement facts panel. Every dose was cross-referenced with published clinical trials to see whether it matches what the studies actually used.

